Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-31
2011-11-08
Ouspenski, Ilia (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
08053414
ABSTRACT:
A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.
REFERENCES:
patent: 4272398 (1981-06-01), Jaffe
patent: 4376110 (1983-03-01), David et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4861719 (1989-08-01), Miller
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4980289 (1990-12-01), Temin et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5124263 (1992-06-01), Temin et al.
patent: 5155020 (1992-10-01), Paoletti
patent: 5155027 (1992-10-01), Sledziewski et al.
patent: 5175099 (1992-12-01), Wills
patent: 5204243 (1993-04-01), Paoletti
patent: 5225336 (1993-07-01), Paoletti
patent: 5225538 (1993-07-01), Capon et al.
patent: 5240846 (1993-08-01), Collins et al.
patent: 5278056 (1994-01-01), Bank et al.
patent: 5284656 (1994-02-01), Platz et al.
patent: 5451569 (1995-09-01), Wong et al.
patent: 5521288 (1996-05-01), Linsley et al.
patent: 5567584 (1996-10-01), Sledziewski et al.
patent: 5675848 (1997-10-01), Kappel
patent: 5714147 (1998-02-01), Capon et al.
patent: 5750375 (1998-05-01), Sledziewski et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 5861310 (1999-01-01), Freeman et al.
patent: 5942607 (1999-08-01), Freeman et al.
patent: 6018026 (2000-01-01), Sledziewski et al.
patent: 6291212 (2001-09-01), Sledziewski et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6300099 (2001-10-01), Sledziewski et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6630575 (2003-10-01), Coyle et al.
patent: 6635750 (2003-10-01), Coyle et al.
patent: 6743619 (2004-06-01), Tang et al.
patent: 6919193 (2005-07-01), Tang et al.
patent: 6965018 (2005-11-01), Mikesell et al.
patent: 7029674 (2006-04-01), Carreno et al.
patent: 7030219 (2006-04-01), Pardoll et al.
patent: 7122351 (2006-10-01), Moore et al.
patent: 7279567 (2007-10-01), Mikesell et al.
patent: 7358354 (2008-04-01), Mikesell et al.
patent: 7368531 (2008-05-01), Rosen et al.
patent: 7381794 (2008-06-01), Moore et al.
patent: 7414122 (2008-08-01), Fox et al.
patent: 7432059 (2008-10-01), Freeman et al.
patent: 7432062 (2008-10-01), Coyle et al.
patent: 7432351 (2008-10-01), Chen
patent: 7560540 (2009-07-01), Pardoll et al.
patent: 7563869 (2009-07-01), Honjo et al.
patent: 7595048 (2009-09-01), Honjo et al.
patent: 7709214 (2010-05-01), Freeman et al.
patent: 7723479 (2010-05-01), Mikesell et al.
patent: 2002/0091246 (2002-07-01), Pardoll et al.
patent: 2002/0095024 (2002-07-01), Mikesell et al.
patent: 2002/0106730 (2002-08-01), Coyle et al.
patent: 2002/0107363 (2002-08-01), Fox et al.
patent: 2002/0110836 (2002-08-01), Freeman et al.
patent: 2002/0164600 (2002-11-01), Freeman et al.
patent: 2003/0142359 (2003-07-01), Bean et al.
patent: 2003/0171551 (2003-09-01), Rosenblatt et al.
patent: 2003/0208058 (2003-11-01), Fiscella et al.
patent: 2003/0232323 (2003-12-01), Freeman et al.
patent: 2004/0010134 (2004-01-01), Rosen et al.
patent: 2005/0228170 (2005-10-01), Fox et al.
patent: 2005/0260716 (2005-11-01), Moore et al.
patent: 2006/0034826 (2006-02-01), Carreno et al.
patent: 2006/0084794 (2006-04-01), Rosen et al.
patent: 2006/0110383 (2006-05-01), Honjo et al.
patent: 2006/0223088 (2006-10-01), Rosen et al.
patent: 2007/0037206 (2007-02-01), Rosen et al.
patent: 2007/0041963 (2007-02-01), Rosen et al.
patent: 2007/0065427 (2007-03-01), Freeman et al.
patent: 2007/0092504 (2007-04-01), Carreno et al.
patent: 2007/0099833 (2007-05-01), Rosen et al.
patent: 2007/0122378 (2007-05-01), Freeman et al.
patent: 2007/0224663 (2007-09-01), Rosen et al.
patent: 2008/0025979 (2008-01-01), Honjo et al.
patent: 2008/0118511 (2008-05-01), Freeman et al.
patent: 2008/0226662 (2008-09-01), Pardoll et al.
patent: 2009/0042292 (2009-02-01), Chen
patent: 2009/0075338 (2009-03-01), Moore et al.
patent: 2009/0269783 (2009-10-01), Coyle et al.
patent: 1074617 (2000-10-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/10741 (1991-07-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/00092 (1992-01-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO93/01222 (1993-01-01), None
patent: WO 95/06464 (1995-02-01), None
patent: WO 95/07707 (1995-03-01), None
patent: WO 97/17613 (1997-05-01), None
patent: WO 97/17614 (1997-05-01), None
patent: WO 97/24447 (1997-07-01), None
patent: WO 98/23635 (1998-06-01), None
patent: WO 98/33914 (1998-08-01), None
patent: WO 99/64597 (1999-12-01), None
patent: WO 00/55375 (2000-09-01), None
patent: WO 00/61612 (2000-10-01), None
patent: WO 01/34629 (2001-05-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 01/94413 (2001-12-01), None
patent: WO 02/00692 (2002-01-01), None
patent: WO 02/00730 (2002-01-01), None
patent: WO 02/02587 (2002-01-01), None
patent: WO 02/02687 (2002-01-01), None
patent: WO 02/08279 (2002-01-01), None
patent: WO 02/02891 (2002-03-01), None
patent: WO 02/24891 (2002-03-01), None
patent: WO 02/057453 (2002-07-01), None
patent: WO 02/078731 (2002-10-01), None
patent: WO 02/079474 (2002-10-01), None
patent: WO 02/081731 (2002-10-01), None
patent: WO 03/008583 (2003-01-01), None
patent: WO 2006/050172 (2006-05-01), None
patent: WO 2008/037080 (2008-04-01), None
patent: WO 2009/029342 (2009-03-01), None
patent: WO 2009/114110 (2009-09-01), None
Singh et al., Nature Biotechnology, 1999, 17: 1075-1081.
GenBank Accession No. AF142780 (1999).
Sequence alignment (2010).
Blazar et al., J. Immunol., 1996, 157: 3250-3259.
Boon et al., Annu. Rev. Immunol., 2006, 24: 175-208.
Nielsen et al., 2000, Cancer Chemother. Pharmacol., 46 (Suppl.): S62-S66.
Lee et al., 1999, J. Immunol., 163: 6292-6300.
Acsadi, et al., “Direct gene transfer and expression into rat heart in vivo”,The New Biologist, 3:71-81 (1991).
Agata, et al., “Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes”,Int. Immunol., 8:765-772 (1996).
Aldovini and Young, “Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines”,Nature, 351:479-482 (1991).
Anderson, “Human gene therapy”,Science, 256:808-813 (1992).
Attwood, et al., “Genomics. The babel of bioinformatics”,Science, 290(5491):471-3 (2000).
Bajorath, et al., “Molecular modeling of CD28 and three-dimensional analysis of residue conservation in the CD28/CD152 family”,J. Mol. Graph. Model., 15:135-139, 108-11 (1997).
Benita, et al., “Characterization of drug-loaded poly(d,l-lactide) microspheres”,J. Pharm. Sci., 73:1721-1724 (1984).
Berman, et al., “The Protein Data Bank”,Nucl. Acids Res., 28:235-242 (2000).
Bona and Hiernaux, et al., “Immune response: Idiotype anti-idiotype network”,CRC Crit. Rev. Immunol., 33-81 (1981).
Bonifaz, et al., “Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance”,J. Exp. Med., 196(12):1627-38 (2002).
Bonifaz, et al., “In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination”,J. Exp. Med., 199(6):815-24 (2004).
Braquet, et al., “Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig”,J. Cardiovascular Pharmacology, 13(S5):S143-S146 (1989).
Chakrabarti, et al., “Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques”,Molec. Cell. Biol., 5:3403-3409 (1985).
Chambers and Al
Gorski Kevin S.
Pardoll Drew M.
Tseng Su-Yi
Tsuchiya Haruo
Ouspenski Ilia
Pabst Patent Group LLP
The Johns Hopkins University
LandOfFree
Methods of using B7-DC molecules to induce or enhance an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using B7-DC molecules to induce or enhance an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using B7-DC molecules to induce or enhance an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4277524